The EU will continue to ban travellers from the U.S. and most other countries beyond July 1, EU diplomats told German news agency dpa.
The report claims that at least 55 per cent of the 27 nation European Union members have signed the list.
According to Euronews, EU officials failed to agree on a common list of the countries that would definitely be banned from entering the block upon the border reopening but managed to create a list of the countries with a better epidemiological situation, the citizens of which will be able to enter Europe by the end of next week.
The European Union (E.U.) is set to reopen its borders on Wednesday, July 1st and due to the COVID-19 pandemic surging in the USA, most travelers from the country will not be permitted to enter.
The Council of the European Union has kept restrictions on travel from the U.S.in place even as it lifts them for 15 other countries including Canada, Australia, New Zealand, South Korea, Japan and China starting tomorrow, July 1.
After tense deliberations, leaders in the European Union have created a list of more than a dozen countries whose residents will be allowed to travel back into the EU's borders once the lockdown lifts later this week, on July 1.
The list was to be reviewed every two weeks and could updated after consultations with the European Commission and the relevant EU agencies and services following an overall assessment based on those criteria above.
Earlier today, Spain announced that it will open its borders with Morocco only if the two countries establish a reciprocal agreement to also allow people from Spain to enter Morocco.
Why US has been left off the list The United States, despite having a large number of its citizens who travel to Europe, has been left off the EU's latest travel list due to the high number of COVID-19 cases being reported there. There are now 15 countries on the draft list for the border to be reopened.
The country's borders have been closed since mid-March in support of the efforts seeking to contain the spread of COVID-19.